Aardvark Therapeutics appoints David Zhang to board
Aardvark Therapeutics said it appointed David Zhang, Ph.D., MBA, to its board of directors effective Oct. 7, 2026. The company said he will serve as an independent director.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Aardvark Therapeutics appoints David Zhang to board
Aardvark Therapeutics appointed David Zhang, Ph.D., MBA, as an independent director effective Oct. 7, 2026.
Aardvark Therapeutics names David Zhang to board
Aardvark Therapeutics (AARD) appointed clinical development leader David Zhang, Ph.D., MBA, to its Board of Directors.